Cargando…
Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner
Neuroprotective strategies are an unmet medical need for Parkinson's disease. Fibroblast growth factor 20 (FGF20) enhances survival of cultured dopaminergic neurons but little is known about its in vivo potential. We set out to examine whether manipulation of the FGF20 system affected nigrostri...
Autores principales: | Boshoff, Eugene.L., Fletcher, Edward.J.R., Duty, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063078/ https://www.ncbi.nlm.nih.gov/pubmed/29698669 http://dx.doi.org/10.1016/j.neuropharm.2018.04.017 |
Ejemplares similares
-
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats
por: Fletcher, Edward J. R., et al.
Publicado: (2019) -
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2019) -
Regulation of bone metabolism by megakaryocytes in a paracrine manner
por: Lee, Young-Sun, et al.
Publicado: (2020) -
In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
por: Masson, Régis, et al.
Publicado: (1998) -
Efficient Reprogramming of Mouse Fibroblasts to Neuronal Cells including Dopaminergic Neurons
por: Oh, Seung-ick, et al.
Publicado: (2014)